How common are liver issues with long term lipitor use?

How common are liver issues with long-term Lipitor use?

Liver function test abnormalities occur in 1 to 3 percent of patients taking atorvastatin, the active ingredient in Lipitor. Long-term studies extending to 5 years show rates that bleiben within this range rather than rising sharply.

What do clinical trials report about liver enzyme elevations?

In controlled trials, persistent elevations of serum transaminases occurred in 0.7 percent of patients on doses ranging from 10 to 80 mg. These values usually returned to normal after discontinuation or dose reduction.

How does Lipitor compare with other statins on liver safety?

Atorvastatin shows similar rates of liver enzyme elevations to other statins such as simvastatin and rosuvastatin. Data from head-to-head trials indicate no consistent advantage or disadvantage relative to competitors.

What happens if liver tests turn abnormal during long-term treatment?

Guidelines recommend stopping the statin if enzymes rise more than three times the upper limit of normal. Most patients experience resolution within weeks after stopping. Re-challenge at a lower dose or switching to a different statin is often successful.

When does the manufacturer advise monitoring?

Pfizer recommends checking liver function tests before treatment starts and repeating them as clinically indicated. No routine periodic monitoring is required for every patient once stable.

Are serious liver injuries rare or frequent?

Serious liver injury, including failure or transplantation, remains very rare with Lipitor. Spontaneous reporting systems record rates below 1 per 100,000 patient-years.

Why are companies challenging this patent?

No.